Fund shareholders of VIVOSIM LABS INC
ISIN US68620A3023 · United States
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 76.2K $
- Share of capital
- 1.2 % of 3.5M shares on Jul 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 22,183 | 48.1K $ | 0.00 % | 0.63 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 15,371 | 22K $ | 0.44 % | as of Mar 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,794 | 3.9K $ | 0.05 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 991 | 2.2K $ | 0.03 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | 0 | 40,339 | +23.5 % |
| 2026Q1 | 4 | 0 | 32,663 | +28.1 % |
| 2025Q4 | 4 | 0 | 25,501 | -19.8 % |
| 2025Q3 | 4 | +3 | 31,791 | +42.1 % |
| 2025Q2 | 1 | 22,374 |
Institutional managers
21 managers declare this company to the SEC (Form 13F).
Declared shareholders of VIVOSIM LABS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Esousa Group Holdings LLC and 1 other | 9.90 % | 286,557 | as of Apr 1, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of VIVOSIM LABS INC". https://titelia.com/en/stocks/vivosim-labs-inc-US68620A3023